Ceftrozy-TZ 1125 Injection
Marketer
Zeelab Pharmacy Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ceftrozy-TZ 1125 Injection
Cef-TZ 1125 Injection, a dual-action antibiotic, combats a range of bacterial infections by inhibiting microbial proliferation. Administration must be solely under medical guidance. Complete the prescribed treatment regimen; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (rash, pruritus, edema, dyspnea) immediately. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration promote optimal recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Ceftrozy-TZ 1125 Injection
Infections caused by bacteria
Major Benefits of Ceftrozy-TZ 1125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftrozy-TZ 1125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftrozy-TZ 1125 Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
How Ceftrozy-TZ 1125 Injection works:
Ceftrozy-TZ 1125 Injection unites Ceftriaxone, a broad-spectrum antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceftrozy-TZ 1125 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftrozy-TZ 1125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to offspring; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Ceftrozy-TZ 1125 Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftrozy-TZ 1125 Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftrozy-TZ 1125 Injection's use in patients suffering from renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Ceftrozy-TZ 1125 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Ceftrozy-TZ 1125 Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftrozy-TZ 1125 Injection :
Omit a Ceftrozy-TZ 1125 Injection dose? Seek your physician's advice.
Facts to Know About Ceftrozy-TZ 1125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |


